Biomarkers Linked with Dynamic Changes of Renal Function in Asymptomatic and Mildly Symptomatic COVID-19 Patients.
Ya-Chieh ChangPing-Huang TsaiYu-Ching ChouKuo-Cheng LuFeng-Yee ChangChia-Chao WuPublished in: Journal of personalized medicine (2021)
The catastrophic coronavirus disease 2019 (COVID-19) pandemic is currently a critical global issue. One well-known complication of COVID-19 in severe cases is acute kidney injury, but no research has given a description of its impact on the kidney in patients with mild symptoms. We explore the renal function changes in mild COVID-19 patients. This retrospective, single-center study included 27 participants with laboratory-detected severe acute respiratory syndrome coronavirus two (SARS-CoV-2) infection who were admitted to the Tri-Service General Hospital from 4 February to 26 May 2020 and analyzed their clinical features, radiological findings, and laboratory data. Data collected upon admission and discharge showed a median estimated glomerular filtration rate (eGFR) of 106.7 mL/min/1.732 m2 and 112.2 mL/min/1.732 m2, respectively, with a p-value of 0.044. A correlation between renal function and the severity of infection was also found and was statistically significant upon admission. Patients with a lower lymphocyte count or higher C-reactive protein, neutrophil count, and neutrophil-to-lymphocyte ratio presented with a decreased eGFR during their early infection phase. The biomarkers (CRP and NLR) may be linked with dynamic changes of renal function in COVID-19 patients who are asymptomatic or have mild symptoms.
Keyphrases
- respiratory syndrome coronavirus
- sars cov
- coronavirus disease
- small cell lung cancer
- acute kidney injury
- epidermal growth factor receptor
- peripheral blood
- electronic health record
- emergency department
- healthcare
- tyrosine kinase
- big data
- mental health
- cardiac surgery
- cross sectional
- sleep quality
- early onset
- machine learning
- depressive symptoms
- physical activity
- data analysis